
Background Susceptibility-weighted imaging (SWI) reveals three forms of cerebral hemorrhagic burden: cerebral microbleeds (CMB), chronic parenchymal hemorrhage, and cortical superficial siderosis (cSS). Prior work has focused on CMB counts, whereas the other two are rarely quantified at scale; their prognostic value in ischemic stroke is thus uncertain. An artificial intelligence (AI) tool to quantify all three at registry scale was developed and tested to determine whether the resulting total hemorrhagic burden (THB) score stratifies risk. Methods The tool was applied to the Clinical Research Collaboration for Stroke in Korea registry (16 sites). After restricting to first-ever ischemic stroke without intravenous thrombolysis or thrombectomy and pre-stroke modified Rankin Scale (mRS) ≤1, 6,124 patients were included in the analysis. THB summed the z-transformed logged values of the three components. Results CMB, parenchymal hemorrhage, and cSS were positive in 45.8%, 17.1%, and 3.4% of patients, respectively, with distinct clinical determinants. THB was associated with 3-month poor outcome (mRS ≥3): adjusted odds ratio (OR) per standard deviation 1.19 (95% CI, 1.11–1.27; P<0.001). The ordinal mRS shift was driven by parenchymal hemorrhage volume (joint-model OR, 1.23 per log unit) and CMB count (OR, 1.19); cSS was directionally consistent but non-significant. Poor-outcome rates rose monotonically across THB tiers, from 18.6% in the lowest to 36.8% in the highest tier. Conclusion An AI tool feasibly quantified all three SWI hemorrhagic findings at the registry scale. The resulting THB composite stratified patients by 3-month functional outcome with a tier-based gradient, thus supporting its use for risk stratification.
Background Intracranial hypertension is a life-threatening condition. Invasive intracranial pressure (ICP) monitoring remains the reference standard; however, catheter-based monitoring is not available for all at-risk intensive care unit patients. We evaluated whether ambient-light-corrected computational pupillometry could provide a bedside rule-out signal using the Pupil Reactivity (PuRe) score. Methods In this prospective single-center pilot study (2025–2026), adults who underwent intraparenchymal ICP monitoring underwent serial computational pupillometry (PuRe Pupillometer, Solvemed Inc.). The PuRe score is a 0–5 measure of pupillary reactivity (0, non-reactive; 0.1–2.9, sluggish; and ≥3, brisk). The primary outcome was diagnostic performance for ICP ≥22 mm Hg at the clinical brisk-reactivity boundary (PuRe score <3), using analyses that accounted for repeated measurements within patients. Results Twenty-six patients were included. At PuRe score <3, negative predictive value was 97.1%, sensitivity 81.1%, specificity 64.5%, and area under the receiver operating characteristic curve 0.77 (95% CI, 0.55–0.92). Mean ICP fell from 30.7 mm Hg with unreactive pupils to 7.6 mm Hg with brisk reactivity, and the inverse PuRe–ICP association held in a mixed-effects model accounting for clustering (slope –1.41 mm Hg per unit, P<0.001). The PuRe score showed no detectable dependence on ambient lighting in the ICP- and patient-adjusted models (P=0.13), whereas the constriction-based metrics remained light-dependent (P<0.001). Conclusion In this small single-center pilot cohort, preserved PuRe reactivity was infrequently accompanied by concurrent ICP ≥22 mm Hg. These preliminary findings support the further validation of ambient-light-corrected computational pupillometry as a potential adjunctive bedside screening, but not as a replacement for invasive monitoring.
Background Intracranial venous hypertension resulting from hemodialysis arteriovenous fistulas (AVFs) is rare and typically linked to central venous occlusive disease (CVOD). Here, we report a case of dural AVF-like cerebral venous reflux without CVOD, caused by a moderate-flow dialysis AVF. Case Report A 71-year-old woman undergoing hemodialysis via a right-arm AVF presented with a seizure-like episode, transient loss of consciousness, and new left-sided weakness with neglect. Computed tomography angiography and magnetic resonance venography revealed diffuse pial venous engorgement and dural sinus hyperenhancement, mimicking a dural AVF. Prior catheter angiography had demonstrated retrograde flow from the AVF through the right internal jugular vein into the superior sagittal sinus without evidence of central venous stenosis or intracranial arterial feeders. Surgical ligation of the AVF resulted in improvement of cerebral edema, papilledema, and neurological deficits. Conclusion Moderate-flow dialysis AVFs can cause symptomatic cerebral venous hypertension in the absence of CVOD. Venous-phase angiography is critical for detecting extracranial reflux and guiding definitive source control.
Background Serotonin syndrome (SS) and malignant hyperthermia (MH) are potentially life-threatening hypermetabolic syndromes that may develop perioperatively. Although both conditions manifest as hyperthermic crises, they have distinct underlying causes and require different management strategies. Case Report We describe the case of a 33-year-old Caucasian man who developed clinical features suggestive of simultaneous SS and MH in a perioperative setting. This rare presentation illustrates the possibility of concurrent SS and MH and underscores the diagnostic challenges in differentiating between these two overlapping hyperthermic syndromes. Conclusion The clinical overlap between SS and MH makes it difficult to distinguish the two conditions, particularly during the perioperative period. This case highlights the importance of recognizing their potential coexistence, and the need for careful consideration of both diagnoses to guide appropriate treatment.
Background Cholinesterase inhibitors (CI) have been associated with prolonged intubation and the occurrence of cholinergic crisis in patients with myasthenic crisis (MC). Thus, recent myasthenia gravis guidelines have tended to recommend the avoidance of this medication. Methods To determine whether there is an association between the continuation of CI and survival and prolonged intubation among patients with MC, data from a previous study that determined the clinical profile of patients with MC were analyzed. Cox regression analysis was performed to determine the possible association between the dependent and independent factors, controlling for all possible confounders. Results On crude analysis, the hazard of dying from any cause when CI was discontinued among patients with MC was found to be barely significantly higher than when it was continued (hazard ratio [HR], 4.1; P=0.054). Nevertheless, when all possible confounders were controlled for, discontinuation of pyridostigmine was associated with a 31.7 times greater hazard of death from all causes than when it was continued (adjusted HR [aHR], 31.7, P=0.009). Continuation of CI was not associated with a prolonged duration of mechanical ventilation, either on crude analysis (HR, 0.84; P=0.66) or after adjusting for confounders (aHR, 0.54; P=0.32). Conclusion Continuation of CI during crisis may improve the survival of patients with MC without worsening respiratory function. However, owing to possible sparse data bias, a randomized controlled trial comparing CI and non-CI groups in the future is recommended to establish an association between CI use and survival.